Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21617532rdf:typepubmed:Citationlld:pubmed
pubmed-article:21617532lifeskim:mentionsumls-concept:C0237401lld:lifeskim
pubmed-article:21617532lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:21617532lifeskim:mentionsumls-concept:C0239946lld:lifeskim
pubmed-article:21617532lifeskim:mentionsumls-concept:C0597198lld:lifeskim
pubmed-article:21617532lifeskim:mentionsumls-concept:C0231221lld:lifeskim
pubmed-article:21617532lifeskim:mentionsumls-concept:C0011155lld:lifeskim
pubmed-article:21617532lifeskim:mentionsumls-concept:C2745888lld:lifeskim
pubmed-article:21617532lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:21617532pubmed:issue8lld:pubmed
pubmed-article:21617532pubmed:dateCreated2011-7-7lld:pubmed
pubmed-article:21617532pubmed:abstractTextAlpha1-antitrypsin deficiency (AATD) is a common genetic cause of chronic liver disease. According to retrospective studies, up to 25% of those with homozygous ZZ (Glu 342 to Lys) AATD suffer from liver cirrhosis and/or liver cancer in late adulthood. We hypothesized that the plasma markers for liver fibrosis, necrosis, and apoptosis may identify AATD individuals at higher risk for liver diseases.lld:pubmed
pubmed-article:21617532pubmed:languageenglld:pubmed
pubmed-article:21617532pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21617532pubmed:citationSubsetIMlld:pubmed
pubmed-article:21617532pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21617532pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21617532pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21617532pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21617532pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21617532pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21617532pubmed:statusMEDLINElld:pubmed
pubmed-article:21617532pubmed:monthAuglld:pubmed
pubmed-article:21617532pubmed:issn1473-5687lld:pubmed
pubmed-article:21617532pubmed:authorpubmed-author:Janciauskiene...lld:pubmed
pubmed-article:21617532pubmed:authorpubmed-author:WelteTobiasTlld:pubmed
pubmed-article:21617532pubmed:authorpubmed-author:PiitulainenEe...lld:pubmed
pubmed-article:21617532pubmed:authorpubmed-author:WallmarkAnder...lld:pubmed
pubmed-article:21617532pubmed:authorpubmed-author:KöhnleinThoma...lld:pubmed
pubmed-article:21617532pubmed:authorpubmed-author:SvegerTomasTlld:pubmed
pubmed-article:21617532pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21617532pubmed:volume23lld:pubmed
pubmed-article:21617532pubmed:ownerNLMlld:pubmed
pubmed-article:21617532pubmed:authorsCompleteYlld:pubmed
pubmed-article:21617532pubmed:pagination716-20lld:pubmed
pubmed-article:21617532pubmed:meshHeadingpubmed-meshheading:21617532...lld:pubmed
pubmed-article:21617532pubmed:meshHeadingpubmed-meshheading:21617532...lld:pubmed
pubmed-article:21617532pubmed:meshHeadingpubmed-meshheading:21617532...lld:pubmed
pubmed-article:21617532pubmed:meshHeadingpubmed-meshheading:21617532...lld:pubmed
pubmed-article:21617532pubmed:meshHeadingpubmed-meshheading:21617532...lld:pubmed
pubmed-article:21617532pubmed:meshHeadingpubmed-meshheading:21617532...lld:pubmed
pubmed-article:21617532pubmed:meshHeadingpubmed-meshheading:21617532...lld:pubmed
pubmed-article:21617532pubmed:meshHeadingpubmed-meshheading:21617532...lld:pubmed
pubmed-article:21617532pubmed:meshHeadingpubmed-meshheading:21617532...lld:pubmed
pubmed-article:21617532pubmed:meshHeadingpubmed-meshheading:21617532...lld:pubmed
pubmed-article:21617532pubmed:meshHeadingpubmed-meshheading:21617532...lld:pubmed
pubmed-article:21617532pubmed:meshHeadingpubmed-meshheading:21617532...lld:pubmed
pubmed-article:21617532pubmed:meshHeadingpubmed-meshheading:21617532...lld:pubmed
pubmed-article:21617532pubmed:meshHeadingpubmed-meshheading:21617532...lld:pubmed
pubmed-article:21617532pubmed:meshHeadingpubmed-meshheading:21617532...lld:pubmed
pubmed-article:21617532pubmed:year2011lld:pubmed
pubmed-article:21617532pubmed:articleTitlePerformance of enhanced liver fibrosis plasma markers in asymptomatic individuals with ZZ ?1-antitrypsin deficiency.lld:pubmed
pubmed-article:21617532pubmed:affiliationDepartment of Respiratory Medicine, Hannover Medical School, Hannover, Germany. annarosa.floreani@unipd.itlld:pubmed
pubmed-article:21617532pubmed:publicationTypeJournal Articlelld:pubmed